TNFSF10 and cancer: TRAIL-based therapies in cancer exhibited very limited therapeutic activity in clinical trials [6,7,8,9], therefore, novel TRAIL formulations with improved bioactivity that can overcome TRAIL resistance would be of utility as cancer treatment [21,22,23,24,25,26].